Disclosed positions

Estimated from their latest filings — positions may have changed since

$245.3K

combined est. value

Stock	Shares	Price	Value	Weight	As of
LYELLyell Immunopharma, Inc.	15,420	$15.91	$245.3K	100%	2026-05-11

LYEL

Lyell Immunopharma, Inc.

$245.3K

15,420 sh

All filings on record

Every Form 4 transaction we track for this filer

all 6buys 0sells 5

Stock	Transaction	Date	~6mo later
LYELLyell Immunopharma, Inc.	Sell $4.1K · 217 sh	2026-05-11	—
LYELLyell Immunopharma, Inc.	Sell $5.9K · 254 sh	2026-02-10	—
LYELLyell Immunopharma, Inc.	Grant — · 8,750 sh	2026-02-10	—
LYELLyell Immunopharma, Inc.	Sell $30.3K · 936 sh	2025-12-30	—
LYELLyell Immunopharma, Inc.	Sell $43.9K · 1,136 sh	2025-12-24	—
LYELLyell Immunopharma, Inc.	Sell $3.8K · 239 sh	2025-11-10	—

LYELSell

2026-05-11 · Lyell Immunopharma, Inc.

$4.1K

—

LYELSell

2026-02-10 · Lyell Immunopharma, Inc.

$5.9K

—

LYELGrant

2026-02-10 · Lyell Immunopharma, Inc.

8,750

—

LYELSell

2025-12-30 · Lyell Immunopharma, Inc.

$30.3K

—

LYELSell

2025-12-24 · Lyell Immunopharma, Inc.

$43.9K

—

LYELSell

2025-11-10 · Lyell Immunopharma, Inc.

$3.8K

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.